info@oncologyventure.com

June 1, 2018, 4:09pm CDT: Oral Presentation of 2X-121 Abstract at ASCO 2018

Ruth Plummer, MD, PhD, FRCP, will present an abstract describing the first-in-human Phase 1 study of 2X-121, an investigational PARP 1/2...

2X Oncology at ESMO 2017

2X Oncology’s Chief Medical Officer Marie Foegh, MD, DrSc, will be attending ESMO 2017, the annual meeting of the European...

2X Oncology at Jefferies Global Healthcare Conference (webcast)

Our chief executive officer, George O. Elston, will present at the Jefferies 2017 Global Healthcare Conference. Date: Friday, June 9,...

2X Oncology at SGO’s Annual Meeting on Woman’s Cancer

March 2017 2X Oncology’s CEO/CMO Marie Foegh, MD, DrSc, will be present at the Society for Gynecological Oncology’s Annual Meeting on...

2X Oncology at Boston Breast Cancer Summit

March 2017 2X Oncology’s CEO/CMO Marie Foegh, MD, DrSc, will be present at the Boston Breast Cancer Summit on March 8 at...

2x Oncology at BioCEO & Investor Conference

February 2017 2X Oncology’s CEO/CMO Marie Foegh, MD, DrSc, presented at the BioCEO & Investor Conference on February 14 at...

2X Oncology at JP Morgan

December 2016 2X Oncology will be presenting to select investors during the JP Morgan Healthcare Conference and at the Biotech...